Would you consider avoidance of AC and proceeding to surgery in a cT2N0 TNBC patient who achieves a significant clinical response to carboplatin, paclitaxel, and pembrolizumab as part of the KEYNOTE-522 regimen?  

What scenarios would you do second neoadjuvant treatment vs surgery?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Warren Alpert Medical School of Brown University
I agree with Dr. @Kelly McCann's response, except ...
Sign in or Register to read more